Zacks: Analysts Expect Five Prime Therapeutics, Inc. (NASDAQ:FPRX) to Post -$0.50 EPS

Retrieved on: 2020-12-08 12:11:29

Tags for this article:

Finance

Money

Alternative investment management companies

Five Prime Therapeutics Inc.

CBOE MARKET VOLATILITY INDEX

Click the tags to see associated articles and topics

Zacks: Analysts Expect Five Prime Therapeutics, Inc. (NASDAQ:FPRX) to Post -$0.50 EPS. View article details on hiswai:

Excerpt

<b>Acadian Asset Management</b> LLC now owns 640,560 shares of the biotechnology company's stock valued at $3,011,000 after acquiring an additional ...

Article found on: www.marketbeat.com

View Original Article